Clinical Applications of Nanotechnology
Course, Master's level, 1TM027
Autumn 2024 Autumn 2024, Uppsala, 100%, On-campus, English
- Location
- Uppsala
- Pace of study
- 100%
- Teaching form
- On-campus
- Instructional time
- Mixed
- Study period
- 9 September 2024–20 September 2024
- Language of instruction
- English
- Entry requirements
-
120 credits in science/engineering/pharmacy including 45 credits in chemistry/chemical engineering/pharmaceutics/biotechnology and 15 credits in cell biology/microbiology. Proficiency in English equivalent to the Swedish upper secondary course English 6.
- Selection
-
All qualified applicants will be admitted.
- Fees
-
If you are not a citizen of a European Union (EU) or European Economic Area (EEA) country, or Switzerland, you are required to pay application and tuition fees.
- First tuition fee instalment: SEK 4,833
- Total tuition fee: SEK 4,833
- Application deadline
- 15 April 2024
- Application code
- UU-14010
Admitted or on the waiting list?
About the course
The course will dwell on the key principles behind modern nanotechnology-enabled clinical treatments. The core of the course will include real-life examples of products authorised for clinical use, covering the fundamental science behind their respective invention, competitor technologies, synthesis and manufacturing principles, key features and benefits as well as the clinical need that they fulfill. The course can be continuously updated with new examples over time.
The following topics will be covered in the course: Basic principles of nanotechnology. Nanocrystals. Super-paramagnetic iron oxide nanoparticles (SPIONs). Lipid-based nanoparticles. Protein-based nanoparticles. Viral and non-viral vectors for gene delivery. Examples of clinical indications of nanomaterials will include cancer and non-cancer treatments.
Reading list
No reading list found.